Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data

American Journal of Neuroradiology

Volumn 25, Issue 9, 2004, Pages 1516-1523

  Dormont, Didier ^a   Ricciardi, Kenneth G ^a   Tandé, Dominique ^a   Parain, Karine ^a   Menuel, Carole ^a   Galanaud, Damien ^a   Navarro, Soledad ^a   Cornu, Philippe ^a   Agid, Yves ^a   Yelnik, Jérôme ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; ADULT; AGED; BRAIN MAPPING; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; FEMALE; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; SENSITIVITY AND SPECIFICITY; STATISTICS; STEREOTAXIC SURGERY;

ADULT; AGED; BRAIN MAPPING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; SENSITIVITY AND SPECIFICITY; STATISTICS; STEREOTAXIC TECHNIQUES; SUBTHALAMIC NUCLEUS;

EID: 16644400942     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-625
2. Voges J, Volkmann J, Allert N, et al. Bilateral high-frequency stimulation in the subthalamic nucleus for the treatment of Parkinson disease: correlation of therapeutic effect with anatomical electrode position. J Neurosurg 2002;96:269-279
3. Pollak P, Benabid AL, Limousin P, Benazzouz A. Chronic intracerebral stimulation in Parkinson's disease. Adv Neurol 1997;74:213-220
4. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-95
5. Carpenter M. The subthalamic region. In: Carpenter M, ed. Human Neuroanatomy. Baltimore: Williams & Wilkins; 1976:509-511
6. Zonenshayn M, Rezai AR, Mogilner AY, Beric A, Sterio D, Kelly PJ. Comparison of anatomic and neurophysiological methods for subthalamic nucleus targeting. Neurosurgery 2000;47:282-294
7. Schuurman PR, de Bie RM, Majoie CB, Speelman JD, Bosch DA. A prospective comparison between three-dimensional magnetic resonance imaging and ventriculography for target-coordinate determination in frame-based functional stereotactic neurosurgery. J Neurosurg 1999;91:911-914
8. Starr PA, Vitek JL, DeLong M, Bakay RA. Magnetic resonance imaging-based stereotactic localization of the globus pallidus and subthalamic nucleus. Neurosurgery 1999;44:303-314
9. Benabid AL, Benazzouz A, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus and of other nuclei as a treatment for Parkinson's disease. Tech Neurosurg 1999;5:5-30
10. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. AJR Am J Roentgenol 1986;147:103-110
11. Drayer BP. Imaging of the aging brain: part I: normal findings. Radiology 1988;166:785-796
12. Thomas LO, Boyko OB, Anthony DC, Burger PC. MR detection of brain iron. AJNR Am J Neuroradiol 1993;14:1043-1048
13. Ordidge RJ, Gorell JM, Deniau JC, Knight RA, Helpern JA. Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla. Magn Reson Med 1994;32:335-341
14. Ye FQ, Allen PS, Martin WR. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov Disord 1996;11:243-249
15. Drayer BP. Basal ganglia: significance of signal hypointensity on T2-weighted MR images. Radiology 1989;173:311-312
16. Chen JC, Hardy PA, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993;14:275-281
17. Gomori JM, Grossman RI. The relation between regional brain iron and T2 shortening. AJNR Am J Neuroradiol 1993;14:1049-1050
18. Yelnik J, Damier P, Demeret S, et al. Localization of stimulating electrodes in patients with Parkinson's disease by using a three-dimensional atlas-magnetic resonance imaging coregistration method. J Neurosurg 2003;99:89-99
19. Schaltenbrand G, Wahren W. Atlas for Stereotaxy of the Human Brain. Georg Thieme Verlag, 1977
20. Yelnik J, Damier P, Bejjani BP, et al. Functional mapping of the human globus pallidus: contrasting effect of stimulation in the internal and external pallidum in Parkinson's disease. Neuroscience 2000;101:77-87
21. Perls M. Evidence for the presence of iron oxide in certain pigments [in German]. Virchows Arch Path Anat 1867;39:42-48
22. Yelnik J. Functional anatomy of the basal ganglia [Suppl 3]. Mov Disord 2002;17:S15-S21
23. Hariz MI, Bergenheim AT. A comparative study on ventriculographic and computerized tomography-guided determinations of brain targets in functional stereotaxis. J Neurosurg 1990;73:565-571
24. Holtzheimer PE III, Roberts DW, Darcey TM. Magnetic resonance imaging versus computed tomography for target localization in functional stereotactic neurosurgery. Neurosurgery 1999;45:290-298
25. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61
26. Tasker RR, Dostrovsky JO, Dolan EJ. Computerized tomography (CT) is just as accurate as ventriculography for functional stereotactic thalamotomy. Stereotact Funct Neurosurg 1991;57:157-166
27. Patel NK, Heywood P, O'Sullivan K, Love S, Gill SS. MRI-directed subthalamic nucleus surgery for Parkinson's disease. Stereotact Funct Neurosurg 2002;78:132-145
28. Egidi M, Rampini P, Locatelli M, et al. Visualisation of the subthalamic nucleus: a multiple sequential image fusion (MuSIF) technique for direct stereotaxic localisation and postoperative control [Suppl 2]. Neurol Sci 2002;23:S71-S72
29. Saint-Cyr JA, Hoque T, Pereira LC, et al. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2002;97:1152-1166
30. Bradley WG, Chen DY, Atkinson DJ, Edelman RE. Fast spin-echo and echo-planar imaging. In: Bradley WG, ed. Magnetic Resonance Imaging. St Louis: Mosby; 1999:125-157
31. Benabid AL, Koudsie A, Benazzouz A, Le Bas JF, Pollak P. Imaging of subthalamic nucleus and ventralis intermedius of the thalamus [Suppl 3]. Mov Disord 2002;17:S123-S129
32. Starr PA, Christine CW, Theodosopoulos PV, et al. Implantation of deep brain stimulators into the subthalamic nucleus: technical approach and magnetic resonance imaging-verified lead locations. J Neurosurg 2002;97:370-387
33. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987;149:365-379
34. Aoki S, Okada Y, Nishimura K, et al. Normal deposition of brain iron in childhood and adolescence: MR imaging at 1.5 T. Radiology 1989;172:381-385
35. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51
36. Milton WJ, Atlas SW, Lexa FJ, Mozley PD, Gur RE. Deep gray matter hypointensity patterns with aging in healthy adults: MR imaging at 1.5 T. Radiology 1991;181:715-719
37. Pujol J, Junque C, Vendrell P, et al. Biological significance of iron-related magnetic resonance imaging changes in the brain. Arch Neurol 1992;49:711-717
38. Francois C, Nguyen-Legros J, Percheron G. Topographical and cytological localization of iron in rat and monkey brains. Brain Res 1981;215:317-322
39. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci 1990;13:254-258
40. Riederer P, Dirr A, Goetz M, Sofic E, Jellinger K, Youdim MB. Distribution of iron in different brain regions and subcellular compartments in Parkinson's disease [Suppl]. Ann Neurol 1992;32:S101-S104
41. Dexter DT, Jenner P, Schapira AH, Marsden CD. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia: The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992;32[suppl]:S94-S100
42. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114:1953-1975